Baird Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.9M | Sell |
|
|||||
|
2025
Q1 | $20M | Sell |
|
|||||
|
2024
Q4 | $22.2M | Sell |
|
|||||
|
2024
Q3 | $21.4M | Sell |
|
|||||
|
2024
Q2 | $18.2M | Buy |
|
|||||
|
2024
Q1 | $14.4M | Sell |
|
|||||
|
2023
Q4 | $20.8M | Sell |
|
|||||
|
2023
Q3 | $21.2M | Sell |
|
|||||
|
2023
Q2 | $31.9M | Buy |
|
|||||
|
2023
Q1 | $22.6M | Buy |
|
|||||
|
2022
Q4 | $21.6M | Sell |
|
|||||
|
2022
Q3 | $18.4M | Sell |
|
|||||
|
2022
Q2 | $18.7M | Sell |
|
|||||
|
2022
Q1 | $26.7M | Buy |
|
|||||
|
2021
Q4 | $31.4M | Sell |
|
|||||
|
2021
Q3 | $43.4M | Sell |
|
|||||
|
2021
Q2 | $43.7M | Sell |
|
|||||
|
2021
Q1 | $41.1M | Buy |
|
|||||
|
2020
Q4 | $34.6M | Sell |
|
|||||
|
2020
Q3 | $39.6M | Buy |
|
|||||
|
2020
Q2 | $44.9M | Buy |
|
|||||
|
2020
Q1 | $35.1M | Sell |
|
|||||
|
2019
Q4 | $33.5M | Sell |
|
|||||
|
2019
Q3 | $47.9M | Buy |
|
|||||
|
2019
Q2 | $49.6M | Sell |
|
|||||
|
2019
Q1 | $50.1M | Buy |
|
|||||
|
2018
Q4 | $35.6M | Buy |
|
|||||
|
2018
Q3 | $34.3M | Sell |
|
|||||
|
2018
Q2 | $32.9M | Sell |
|
|||||
|
2018
Q1 | $36.1M | Buy |
|
|||||
|
2017
Q4 | $31.6M | Sell |
|
|||||
|
2017
Q3 | $36.8M | Sell |
|
|||||
|
2017
Q2 | $51.8M | Buy |
|
|||||
|
2017
Q1 | $42.2M | Buy |
|
|||||
|
2016
Q4 | $23.6M | Sell |
|
|||||
|
2016
Q3 | $30.2M | Buy |
|
|||||
|
2016
Q2 | $30.4M | Buy |
|
|||||
|
2016
Q1 | $28.9M | Buy |
|
|||||
|
2015
Q4 | $31.8M | Buy |
|
|||||
|
2015
Q3 | $28.2M | Buy |
|
|||||
|
2015
Q2 | $28.1M | Buy |
|